Dr. Steve McCune

Claim this profile

Northwest Georgia Oncology Centers, P.C.

Studies Transitional Cell Carcinoma
Studies Bladder Cancer
1 reported clinical trial
2 drugs studied

Area of expertise

1Transitional Cell Carcinoma
Steve McCune has run 1 trial for Transitional Cell Carcinoma. Some of their research focus areas include:
HER2 positive
Stage III
Stage IV
2Bladder Cancer
Steve McCune has run 1 trial for Bladder Cancer. Some of their research focus areas include:
HER2 positive
Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.
Northwest Georgia Oncology Centers, P.C.

Clinical Trials Steve McCune is currently running

Image of trial facility.

Disitamab Vedotin + Pembrolizumab

for Bladder Cancer

This trial is testing a new drug called disitamab vedotin, alone or with pembrolizumab, for patients with advanced or metastatic HER2 expressing bladder cancer. Disitamab vedotin is designed to target HER2 and has been approved for other types of cancer. The study aims to see if these drugs can effectively treat the cancer and what side effects they might cause.
Recruiting1 award Phase 24 criteria

More about Steve McCune

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Steve McCune has experience with
  • Disitamab Vedotin
  • Pembrolizumab
Breakdown of trials Steve McCune has run
Transitional Cell Carcinoma
Bladder Cancer
Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steve McCune specialize in?
Steve McCune focuses on Transitional Cell Carcinoma and Bladder Cancer. In particular, much of their work with Transitional Cell Carcinoma has involved HER2 positive patients, or patients who are Stage III.
Is Steve McCune currently recruiting for clinical trials?
Yes, Steve McCune is currently recruiting for 1 clinical trial in Marietta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Steve McCune has studied deeply?
Yes, Steve McCune has studied treatments such as Disitamab Vedotin, Pembrolizumab.
What is the best way to schedule an appointment with Steve McCune?
Apply for one of the trials that Steve McCune is conducting.
What is the office address of Steve McCune?
The office of Steve McCune is located at: Northwest Georgia Oncology Centers, P.C., Marietta, Georgia 30060 United States. This is the address for their practice at the Northwest Georgia Oncology Centers, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top